Related content

Water-soluble compounds in the herbal preparation Abana inhibit lipid biosynthesis and enhance cholesterol efflux in HepG₂ cells

By Vidyashankar Satyakumar   Godavarthi Ashok   Varma R. S.   Nandakumar Krishna S.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 4, 2010-04 ,pp. : 456-464

NRC Research Press

Access to resources Recommend Favorite

Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?

By Gaist David   García Rodríguez Luis Alberto   Huerta Consuelo   Hallas Jesper   Sindrup Søren H.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 12, 2001-03 ,pp. : 931-933

Springer Publishing Company

Access to resources Recommend Favorite

Metformin modulates insulin receptor signaling in normal and cholesterol-treated human hepatoma cells (HepG2)

By Meuillet E.J.   Wiernsperger N.   Mania-Farnell B.   Hubert P.   Cremel G.  

European Journal of Pharmacology, Vol. 377, Iss. 2, 1999-07 ,pp. : 241-252

Elsevier

Access to resources Recommend Favorite

Effect of FR194738, a potent inhibitor of squalene epoxidase, on cholesterol metabolism in HepG2 cells

By Sawada M.   Matsuo M.   Hagihara H.   Tenda N.   Nagayoshi A.   Okumura H.   Washizuka K.-i.   Seki J.   Goto T.  

European Journal of Pharmacology, Vol. 431, Iss. 1, 2001-11 ,pp. : 11-16

Elsevier

Access to resources Recommend Favorite

Effects of Lipid-Lowering Agents on Inflammation, Haemostasis and Blood Pressure

By  

Current Pharmaceutical Design, Vol. 20, Iss. 40, 2014-12 ,pp. : 6306-6313

Bentham Science Publishers

Access to resources Recommend Favorite